Cresco acted as lead counsel to Novalis and Qbic on their Series A investment in Trince.
Trince, a spin-off of Ghent University (UGent), is developing innovative and efficient technology to insert genetic material into cells. This genetic modification of cells is essential in, for example, cell therapy – an anti-cancer treatment that has become an integral part of modern medicine.
Trince has raised EUR 4 million from Novalis Biotech Acceleration, Qbic II, and private investors.
Olivier van Raemdonck led the Cresco team that advised the investors in this transaction.
More information on this transaction can be found in De Tijd.
For any further information or questions, please contact Olivier van Raemdonck.
Lange Kievitstraat 118-120
2018 Antwerp
Kempische Steenweg 293/16
3500 Hasselt
Foreestelaan 1
9000 Gent
© 2024 CRESCO – All rights reserved – Terms of Use – General terms & conditions – Privacy Policy – Cookie Policy – Design & development by Concepstudio
Cookie | Duration | Description |
---|---|---|
cookielawinfo-checbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-advertisement | 1 year | Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Advertisement" category . |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
CookieLawInfoConsent | 1 year | Records the default button state of the corresponding category & the status of CCPA. It works only in coordination with the primary cookie. |
elementor | never | This cookie is used by the website's WordPress theme. It allows the website owner to implement or change the website's content in real-time. |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |